Open Outbreak

Respiratory season (influenza, COVID-19, RSV)

Pathogen: Seasonal influenza, SARS-CoV-2, RSV · Region: Worldwide · Status: active · Attention: high · Updated

OfficialMedia, unverifiedReported this week
Deaths—2,248 as of 10 Nov 2026—
Confirmed cases—2,621,031 as of 10 Nov 2026—
Suspected cases—14 as of 15 Oct 2026—
Hospitalised2 as of 18 Oct 2026843,312 as of 11 Nov 2026—

Official and media figures describe the same people from different vantage points and are never added together.

Respiratory-virus activity remains ongoing, but the evidence collected for 2026-11-09 through 2026-11-15 does not establish a synchronized global surge. The clearest current official update is from UKHSA: influenza and RSV hospital activity increased while remaining low, and COVID-19 activity was stable at low levels. Its bulletin, published on 2026-11-12, covers the week ending 2026-11-08, illustrating the reporting lag behind this assessment. A US newspaper report collected on 2026-11-13 describes an unusually early influenza season affecting the South and West. It attributes substantial illness, hospitalization and death estimates to CDC, but the underlying CDC update was not retrieved, so those figures remain media-reported rather than independently verified official totals. Much of the topic's collected material is unverified, unrelated or incorrectly classified; it cannot support a global case count or growth estimate. Current conditions in Asia, Latin America, Africa and Oceania are insufficiently documented in this session. These are established respiratory infections, with substantial risks for vulnerable people even when population-level activity is low. Influenza and COVID-19 vaccination, influenza antivirals, and RSV vaccination or infant antibody protection provide useful countermeasures, but access and eligibility differ. Watch for sustained increases in hospital admissions, simultaneous peaks that strain healthcare, reduced protection against severe illness, antiviral resistance, and variants with demonstrated changes in severity or spread. No newly emerging strain or current WHO high-risk declaration was verified here.

Efficient respiratory transmission and circulation in connected countries can produce substantial hospital burden, especially when seasonal peaks overlap. Verified current trends are modest rather than explosive, and useful preventive measures exist, although access and treatment options are uneven. Sparse global evidence does not establish a novel threat, a synchronized surge or a current WHO high-risk declaration.

Situation as of 15 Nov 2026

Official

UKHSA's 2026-11-12 bulletin reports low influenza activity with small increases, stable low COVID-19 activity, and increasing but low RSV hospital activity for 2026-11-02 through 2026-11-08. Influenza hospital admissions rose from 3.00 to 3.65 per 100,000; COVID-19 admissions were stable at 2.22 versus 2.23 per 100,000; RSV admissions rose from 0.89 to 1.30 per 100,000. These are weekly rates, not patient totals. The retrieved WHO seasonal-influenza DON is dated 2025-12-10 and describes that earlier season as within expected global seasonal ranges; it is not a current 2026 assessment. Current global WHO, ECDC and direct CDC assessments were not verified.

Media, unverified

A US article collected on 2026-11-13 describes a very early influenza season affecting the South and West. The tracker extracted CDC-attributed figures of 2,600,000 illnesses/cases, 36,000 hospitalizations and 2,100 deaths from this media item. The article text and underlying CDC source were not retrieved, so their time period, estimation method and case definition remain unverified. Other collected coverage emphasizes winter hospital pressure and vaccination preparedness, much of it predating this cadence window.

Control measures

UKHSA is publishing weekly multi-virus surveillance and urging eligible people to receive NHS vaccination. UK government announcements collected on 2026-11-12 concern seasonal influenza vaccine-uptake statistics, but do not establish actual uptake or available stock. Established countermeasures include seasonal influenza vaccination and antivirals, COVID-19 vaccination, and RSV maternal or older-adult vaccination and infant antibody protection where available. Current international stockpile levels, shortages and equitable access were not verified. No new broad quarantine, closure, border restriction or travel-screening measure was verified.

Timeline

Latest reports

  1. · theguardian.com · Media, unverified
    The best way to avoid winter illness | Letters
  2. · manchestereveningnews.co.uk · Media, unverified
    Vet expert explains how to stop your dogs from catching colds as winter flu season begins
  3. · whyy.org · Media, unverified
    Flu season off to an early start in Philadelphia region with more cases and more severe symptoms
  4. · independent.co.uk · Media, unverified
    Eight simple ways you can boost your immune system this winter
  5. · npr.org · Media, unverified
    More people are getting the flu. Should you get a flu shot before you travel?
  6. · independent.co.uk · Media, unverified
    Flu or just a common cold? Here’s how to tell the difference
  7. · independent.co.uk · Media, unverified
    The US flu season is off to a very early start. It's targeting the South and West now
  8. · Reddit · r/publichealth · Media, unverified
    Flu Forecast Game - Community forecasting to improve early warning systems
  9. · gov.uk · Media, unverified
    Official Statistics: Seasonal flu vaccine uptake in children of school age: 1 September 2026 to 31 October 2026
  10. · gov.uk · Media, unverified
    Official Statistics: Seasonal flu vaccine uptake in GP patients: 1 September 2026 to 31 October 2026
  11. · myjoyonline.com · Media, unverified
    Beyond Bananas: How Golden Exotics holds a blueprint for Ghana’s agricultural transformation
  12. · post-gazette.com · Media, unverified
    Gretchen’s table: Italian wedding soup keeps you warm during cold and flu season